Program News
News and stories about the UNC Lineberger Cancer Genetics Program
-
Nanotechnology offers lower cost, high accuracy approach to diagnosing leukemias in low resource countries
A newer, less expensive nanotechnology may make it possible to more accurately diagnose children with acute leukemia in lower income countries, according to findings by Thomas Alexander, MD, MPH, and colleagues.
-
Local athlete benefits from UNC Lineberger physician’s expertise
Local football player Troy Ennis and his family go through a rare cancer diagnosis and treatment together, relying on the expertise of UNC Lineberger’s Ian Davis, MD.
-
Expanded community data project will improve understanding of cancer
UNC Lineberger’s Office of Community Outreach and Engagement has begun a major, new data-driven initiative that will comprehensively describe the cancer burden in North Carolina.
-
Molecular aspects of ovarian and endometrial tumors mapped to the level of a single cell
Researchers led by Hector L. Franco, PhD, have determined for the first time, cell-by-cell, the genetic and epigenetic state of ovarian and endometrial tumors.
-
Susan G. Komen announces $1.5 million in grants for metastatic breast cancer research
Susan G. Komen has awarded three grants in support of metastatic breast cancer research as part of a collaboration between Komen, UNC Lineberger and Duke Cancer Institute, called the Susan G. Komen Metastatic Breast Cancer Collaborative Research Initiative.
-
New vulnerability found in lung squamous cancer may facilitate drug targeting at the cellular level
New research by Chad Pecot, MD, and colleagues shows the potential for targeting a specific circular RNA, known as CDR1as, to attack lung squamous cell cancer.
-
Ramsden, Gupta awarded 5-year, $8.8 million grant to study an enzyme that has important implications for breast and ovarian cancer
Dale Ramsden, PhD, Gaorav Gupta, MD, PhD, and team will study an enzyme that is part of an important pathway that repairs damage to genomes.
-
Nobel laureate Sancar named recipient of 2019 Hyman L. Battle Distinguished Cancer Research Award
UNC Lineberger’s Aziz Sancar, MD, PhD, has been named the 2019 recipient of the Hyman L. Battle Distinguished Cancer Research Award.